Additional Paid in Capital in USD of Silo Pharma, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Summary
Silo Pharma, Inc. quarterly Additional Paid in Capital history and change rate from Q4 2010 to Q3 2025.
  • Silo Pharma, Inc. Additional Paid in Capital for the quarter ending September 30, 2025 was $23.6M, a 16.3% increase year-over-year.
Additional Paid in Capital, Quarterly (USD)
Additional Paid in Capital, YoY Quarterly Change (%)

Silo Pharma, Inc. Quarterly Additional Paid in Capital (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $23.6M +$3.3M +16.3% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $22.4M +$3.21M +16.7% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $20.3M +$2.77M +15.8% Mar 31, 2025 10-Q 2025-05-09
Q4 2024 $20.3M +$2.77M +15.8% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 $20.3M +$2.89M +16.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $19.2M +$1.79M +10.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $17.5M +$9.89K +0.06% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $17.5M +$14.1K +0.08% Dec 31, 2023 10-K 2025-03-28
Q3 2023 $17.4M +$48.1K +0.28% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $17.4M +$5.02M +40.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $17.5M +$5.11M +41.1% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $17.5M +$5.19M +42.1% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 $17.4M +$5.05M +41% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $12.4M +$74.2K +0.6% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 $12.4M +$93.5K +0.76% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $12.3M +$5.29M +75.2% Dec 31, 2021 10-K 2023-03-24
Q3 2021 $12.3M +$5.28M +75.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $12.3M +$5.68M +85.6% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $12.3M +$9.69M +368% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $7.03M +$4.4M +167% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $7.03M +$4.86M +224% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $6.63M +$4.53M +215% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $2.63M +$574K +27.9% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $2.63M +$583K +28.5% Dec 31, 2019 10-K/A 2021-05-17
Q3 2019 $2.17M -$805 -0.04% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $2.11M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $2.06M Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $2.05M +$177K +9.44% Dec 31, 2018 10-K 2020-03-20
Q3 2018 $2.17M Sep 30, 2018 10-Q 2018-11-14
Q4 2017 $1.87M Dec 31, 2017 10-K 2019-04-04
Q4 2013 $2.92M +$1.8M +160% Dec 31, 2013 10-K 2014-03-31
Q3 2013 $1.86M +$735K +65.5% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $1.54M +$420K +37.4% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $1.14M +$20K +1.78% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $1.12M $0 0% Dec 31, 2012 10-K 2014-03-31
Q3 2012 $1.12M $0 0% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $1.12M $0 0% Jun 30, 2012 10-Q 2012-08-01
Q1 2012 $1.12M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $1.12M $0 0% Dec 31, 2011 10-K 2013-03-05
Q3 2011 $1.12M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 $1.12M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $1.12M Dec 31, 2010 10-K 2012-01-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.